Engineered phage enzymes against drug-resistant pathogens: a review on advances and applications

Mohadeseh Hassannia1, Mahin Naderifar2, Shakiba Salamy3

  • 1Department of Genetic, Faculty of Science, Islamic Azad University, Tehran, Iran.

PubMed

Insights

Genetically engineered phage enzymes (EPE) offer a promising solution to combat multi and extensively drug-resistant bacteria. These novel enzymes show superior performance over natural endolysins and phages in treating resistant infections.

Area of Science:

  • Microbiology
  • Biotechnology

Background:

  • Rising rates of multi and extensively drug-resistant (MDR and XDR) bacteria pose significant global health threats.
  • Bacterial infections linked to drug resistance contribute to increased morbidity and mortality.
  • Endolysins, phage-encoded enzymes, degrade bacterial cell walls, offering a potential antimicrobial strategy.

Purpose of the Study:

  • To review novel knowledge on genetically engineered phage enzymes (EPE) as a therapeutic strategy.
  • To highlight the enhanced performance of EPE compared to natural endolysins and phages.
  • To provide information relevant for clinical trials involving EPE.

Main Methods:

  • Review of existing literature on endolysins and genetically engineered phage enzymes.
  • Analysis of studies demonstrating the efficacy of EPE against antibiotic-resistant bacteria.
  • Focus on the potential of EPE in therapeutic and prophylactic applications.

Main Results:

  • Genetically engineered phage enzymes (EPE) exhibit superior performance in combating antibiotic-resistant infections.
  • EPE demonstrate unique properties for therapeutic and prophylactic applications.
  • These engineered enzymes accelerate phage research and therapeutic development.

Conclusions:

  • EPE represent a significant advancement in the fight against drug-resistant bacterial infections.
  • The unique properties of EPE offer new therapeutic options across human, veterinary, agricultural, and biotechnological sectors.
  • Further research and clinical trials involving EPE are warranted to fully realize their potential.

Related Concept Videos

Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
70.8K
Biological Methods for Microbial Control01:28

Biological Methods for Microbial Control

Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
35
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
23
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
35
DNA Bacteriophages01:26

DNA Bacteriophages

Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
27
CRISPR and crRNAs02:53

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.0K